These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 33058535)
1. Effectiveness of pirfenidone for idiopathic pulmonary fibrosis associated with pleuroparenchymal fibroelastosis-like lesions and nonspecific interstitial pneumonia. Sakamoto S; Shimizu H; Isshiki T; Nakamura Y; Kurosaki A; Isobe K; Homma S Clin Respir J; 2021 Mar; 15(3):272-279. PubMed ID: 33058535 [TBL] [Abstract][Full Text] [Related]
2. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients. Feng H; Zhao Y; Li Z; Kang J Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic finding on high-resolution computed tomography (HRCT) predicts a good response to pirfenidone in patients with idiopathic pulmonary fibrosis. Ma M; Cao M; Gao Y; Qiu X; Jiang H; Cai H Medicine (Baltimore); 2023 May; 102(19):e33722. PubMed ID: 37171315 [TBL] [Abstract][Full Text] [Related]
4. Usual interstitial pneumonia end-stage features from explants with radiologic and pathological correlations. Rabeyrin M; Thivolet F; Ferretti GR; Chalabreysse L; Jankowski A; Cottin V; Pison C; Cordier JF; Lantuejoul S Ann Diagn Pathol; 2015 Aug; 19(4):269-76. PubMed ID: 26025258 [TBL] [Abstract][Full Text] [Related]
5. Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis. Vancheri C; Sebastiani A; Tomassetti S; Pesci A; Rogliani P; Tavanti L; Luppi F; Harari S; Rottoli P; Ghirardini A; Kirchgaessler KU; Albera C Respir Med; 2019 Sep; 156():78-84. PubMed ID: 31445389 [TBL] [Abstract][Full Text] [Related]
6. Pleuroparenchymal fibroelastosis-like lesions in patients with interstitial pneumonia diagnosed by multidisciplinary discussion with surgical lung biopsy. Sumikawa H; Johkoh T; Egashira R; Sugiura H; Yamano Y; Kataoka K; Kondoh Y; Arakawa H; Nakamura M; Kuriu A; Nakanishi K; Tomiyama N Eur J Radiol Open; 2020; 7():100298. PubMed ID: 33354595 [TBL] [Abstract][Full Text] [Related]
7. Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia. Sugino K; Ono H; Shimizu H; Kurosawa T; Matsumoto K; Ando M; Mori K; Tsuboi E; Homma S; Kishi K ERJ Open Res; 2021 Jan; 7(1):. PubMed ID: 33681342 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: a case-control study. Sakamoto S; Muramatsu Y; Satoh K; Ishida F; Kikuchi N; Sano G; Sugino K; Isobe K; Takai Y; Homma S Respirology; 2015 Apr; 20(3):445-52. PubMed ID: 25639750 [TBL] [Abstract][Full Text] [Related]
9. Distinct characteristics of pleuroparenchymal fibroelastosis with usual interstitial pneumonia compared with idiopathic pulmonary fibrosis. Oda T; Ogura T; Kitamura H; Hagiwara E; Baba T; Enomoto Y; Iwasawa T; Okudela K; Takemura T; Sakai F; Hasegawa Y Chest; 2014 Nov; 146(5):1248-1255. PubMed ID: 25367470 [TBL] [Abstract][Full Text] [Related]
10. The Effectiveness, Safety, and Tolerability of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Retrospective Study. Hanta I; Cilli A; Sevinc C Adv Ther; 2019 May; 36(5):1126-1131. PubMed ID: 30900199 [TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Monaghan H; Wells AU; Colby TV; du Bois RM; Hansell DM; Nicholson AG Chest; 2004 Feb; 125(2):522-6. PubMed ID: 14769733 [TBL] [Abstract][Full Text] [Related]
12. Gremlin localization and expression levels partially differentiate idiopathic interstitial pneumonia severity and subtype. Myllärniemi M; Vuorinen K; Pulkkinen V; Kankaanranta H; Aine T; Salmenkivi K; Keski-Oja J; Koli K; Kinnula V J Pathol; 2008 Mar; 214(4):456-63. PubMed ID: 18072275 [TBL] [Abstract][Full Text] [Related]
13. Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases. Torrisi SE; Kahn N; Wälscher J; Sarmand N; Polke M; Lars K; Eichinger M; Heussel CP; Palmucci S; Sambataro FM; Sambataro G; Sambataro D; Vancheri C; Kreuter M BMC Pulm Med; 2019 Nov; 19(1):213. PubMed ID: 31718637 [TBL] [Abstract][Full Text] [Related]
14. Idiopathic pulmonary fibrosis: Significance of the usual interstitial pneumonia (UIP) CT-scan patterns defined in new international guidelines. Diridollou T; Sohier L; Rousseau C; Angibaud A; Chauvin P; Gaignon T; Tas M; Lemerre J; Kerjouan M; Salé A; Lederlin M; Jouneau S Respir Med Res; 2020 Mar; 77():72-78. PubMed ID: 32416587 [TBL] [Abstract][Full Text] [Related]
15. Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia. Parra ER; Kairalla RA; Ribeiro de Carvalho CR; Eher E; Capelozzi VL Respiration; 2007; 74(2):159-69. PubMed ID: 17108669 [TBL] [Abstract][Full Text] [Related]
16. Interstitial pneumonia related to undifferentiated connective tissue disease: pathologic pattern and prognosis. Kim HC; Ji W; Kim MY; Colby TV; Jang SJ; Lee CK; Han SB; Kim DS Chest; 2015 Jan; 147(1):165-172. PubMed ID: 25211168 [TBL] [Abstract][Full Text] [Related]
17. Prognosis of pulmonary fibrosis presenting with a usual interstitial pneumonia pattern on computed tomography in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-related nephritis: a retrospective single-center study. Watanabe T; Minezawa T; Hasegawa M; Goto Y; Okamura T; Sakakibara Y; Niwa Y; Kato A; Hayashi M; Isogai S; Kondo M; Yamamoto N; Hashimoto N; Imaizumi K BMC Pulm Med; 2019 Nov; 19(1):194. PubMed ID: 31675941 [TBL] [Abstract][Full Text] [Related]
18. The histopathology of idiopathic pulmonary fibrosis in West Highland white terriers shares features of both non-specific interstitial pneumonia and usual interstitial pneumonia in man. Syrjä P; Heikkilä HP; Lilja-Maula L; Krafft E; Clercx C; Day MJ; Rönty M; Myllärniemi M; Rajamäki MM J Comp Pathol; 2013; 149(2-3):303-13. PubMed ID: 23664319 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis. Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H Respir Med; 2019; 154():122-126. PubMed ID: 31238182 [TBL] [Abstract][Full Text] [Related]
20. Predictive factors for the long-term use of pirfenidone in patients with fibrosing interstitial lung disease. Katano T; Sekine A; Ikeda S; Yamakawa H; Misumi T; Okabayashi H; Okuda R; Kitamura H; Baba T; Komatsu S; Hagiwara E; Ogura T Respir Investig; 2021 Jul; 59(4):414-420. PubMed ID: 33618993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]